QIAGEN (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced a major milestone, surpassing 1,000 placements of its EZ2 Connect automated sample preparation instrument, a key advancement in the EZ1 instrument…
University Medical Devices (UMD), a leader in healthcare technology innovation, has announced the launch of its first specimen collection solution, MicroWash. Developed at the onset of the COVID-19 pandemic, MicroWash…
Agiliti, a leading provider of medical device solutions, has announced the launch of its new Adapt Line™ of therapeutic hospital support surfaces. These surfaces are clinically designed to improve patient…
Carlsmed, Inc., a MedTech company specializing in AI-driven personalized spine surgery, today announced that it has received FDA 510(k) clearance for the aprevo® Cervical ACDF Interbody System. This achievement highlights…
GE HealthCare (Nasdaq: GEHC) has announced the 510(k) submission for CleaRecon DL, a deep learning technology aimed at enhancing the quality of cone-beam computed tomography (CBCT) images. This AI-powered 3D…
Radiology Partners (RP), the leading radiology practice in the U.S., and RADPAIR, a leader in generative AI-driven radiology solutions, have announced a strategic partnership aimed at advancing innovation in radiology…
Neo Medical SA, a Swiss company specializing in spine surgery technology, has announced that its entire product portfolio has received approval under the European Union’s Medical Device Regulation (MDR) EU…
GE HealthCare (Nasdaq: GEHC) has introduced Sonic DL for 3Dii, the latest innovation in its effortless imaging portfolio, aimed at accelerating MRI scans across a wide range of clinical applications.…
QIAGEN (NYSE: QGEN; Frankfurt Prime Standard: QIA) today revealed plans to relocate its QIAstat-Dx operations to a new facility in Esplugues de Llobregat, near Barcelona. This move is part of…
The 2024 National Diabetes Care Survey, a comprehensive analysis of Type 2 diabetes patients in the U.S., highlights the growing impact of cellular remote patient monitoring (RPM)™ on diabetes management.…
BioIntelliSense, a leader in continuous health monitoring and clinical intelligence, today announced the publication of peer-reviewed research in the Journal of Clinical Medicine. The study, titled “A Retrospective Observational Study…
Exai Bio, a next-generation company specializing in oncRNA and generative AI-based liquid biopsy technologies, has announced the publication of a peer-reviewed paper in Nature Communications. The study, titled “Deep generative…